Kinarus Therapeutics Holding AG (XSWX:KNRS) ROCE % : -1,670.00% (As of Dec. 2021)

View and export this data going back to 1999. Start your Free Trial

What is Kinarus Therapeutics Holding AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kinarus Therapeutics Holding AG's annualized ROCE % for the quarter that ended in Dec. 2021 was -1,670.00%.

Kinarus Therapeutics Holding AG ROCE % Historical Data

The historical data trend for Kinarus Therapeutics Holding AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kinarus Therapeutics Holding AG ROCE % Chart

Kinarus Therapeutics Holding AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROCE %

Get a 7-Day Free Trial

-15.51

-76.58

-164.56

0.80

-500.00

Kinarus Therapeutics Holding AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
ROCE %	Get a 7-Day Free Trial															-155.79	155.65	-1,910.00	435.29	-1,670.00

Kinarus Therapeutics Holding AG ROCE % Calculation

Kinarus Therapeutics Holding AG's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	-0.13	/	( ( (0.127 - 0.104)	+	(0.136 - 0.107) )	/ 2 )
	=	-0.13	/	( (0.023	+	0.029)	/ 2 )
	=	-0.13	/	0.026
	=	-500.00 %

Kinarus Therapeutics Holding AG's ROCE % of for the quarter that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2021 )		(Q: Jun. 2021 )		(Q: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2021 )		(Q: Jun. 2021 )		(Q: Dec. 2021 )
	=	-0.334	/	( ( (0.181 - 0.17)	+	(0.136 - 0.107) )	/ 2 )
	=	-0.334	/	( ( 0.011	+	0.029 )	/ 2 )
	=	-0.334	/	0.02
	=	-1,670.00 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2021) EBIT data.

Kinarus Therapeutics Holding AG (XSWX:KNRS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kinarus Therapeutics Holding AG ROCE % Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Kinarus Therapeutics Holding AG (XSWX:KNRS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3, Avenue de Florimont, Lausanne, CHE, CH-1006

Website

https://www.perfect.aero

Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The company operates in one business segment which includes Charters. The products provided by the company include Aircraft sales, Charter sales, and Aircraft consultancy.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Headlines

No Headlines